Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

Author： Chondropoulos Spyridon Dimitrios   Delastic Annaliza   Spyridonidis Alexandros  

Publisher： Springer Publishing Company

ISSN： 1865-5041

Source： memo - Magazine of European Medical Oncology, Vol.6, Iss.4, 2013-12, pp. : 271-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeting of AML-leukemic stem cells with monoclonal antibodies

By Lee Erwin M   Lock Richard B  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1327-1330

Future Medicine

Access to resources Recommend Favorite

Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions

By Paterlini-Bréchot P.   vona G.   Bréchot C.  

Seminars in Cancer Biology, Vol. 10, Iss. 3, 2000-06 ,pp. : 241-249

Academic Press

Access to resources Recommend Favorite

Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond

By Katz Ben-Zion   Herishanu Yair  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 999-1006

Informa Healthcare

Access to resources Recommend Favorite

Advances and Future Directions in the Targeting of HER2-positive Breast Cancer: Implications for the Future

By Subbiah Ishwaria   Gonzalez-Angulo Ana  

Current Treatment Options in Oncology, Vol. 15, Iss. 1, 2014-03 ,pp. : 41-54

Springer Publishing Company

Access to resources Recommend Favorite

Thermal tumour ablation: Devices, clinical applications and future directions

By Haemmerich D.   Laeseke P. F.  

International Journal of Hyperthermia, Vol. 21, Iss. 8, 2005-12 ,pp. : 755-760

Informa Healthcare

Access to resources Recommend Favorite